Lexi Pharma Inc.
Records under this name other than patents Lexi Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Lexi Pharma Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,135,212 | Method for treating osteoporosis, osteopenia or low bone mineral density Formerly held Lapsed on the fee record Ended Oct 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 5, 2025 | From the USPTO record |
| US 9,725,471 | Method to prevent cancer metastasis to bone Formerly held Lapsed on the fee record Ended Aug 8, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 8, 2025 | From the USPTO record |
| US 10,933,021 | Compositions of gallium (III) complexes for oral administration Formerly held Lapsed on the fee record Ended Mar 2, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 2, 2025 | From the USPTO record |
| US 10,548,849 | Compositions of gallium (III) complexes for oral administration Formerly held Lapsed on the fee record Ended Feb 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Feb 4, 2024 | From the USPTO record |
| US 10,463,657 | Method for treating osteoporosis, osteopenia or low bone mineral density Formerly held Lapsed on the fee record Ended Nov 5, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 5, 2023 | From the USPTO record |